Acquiring Company
CorMedix
Acquired Company
Heron Therapeutics
Berkeley HeightsSan DiegoBiotechnologyHealth CareTherapeuticsDescription
On November 9, 2026, CorMedix Inc. announced the execution of a definitive asset purchase agreement to acquire substantially all of the assets of Heron Therapeutics, Inc. This strategic move was disclosed during a conference call and webcast for investors. The transaction is expected to enhance CorMedix's product portfolio and capabilities.
Quick answer
CorMedix is acquiring Heron Therapeutics, announced November 10, 2026. CorMedix is based in Berkeley Heights, New Jersey, United States.
- How much did CorMedix pay for Heron Therapeutics?
- The deal value was not disclosed.
- What does CorMedix do?
- CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.
- Where are CorMedix and Heron Therapeutics based?
- CorMedix is based in Berkeley Heights, New Jersey, United States. Heron Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at CorMedix?
- Fundz holds 1 contact at CorMedix. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Biossil Labs Inc. Acquires SYN-004 and Related Assets from Theriva Biologics, Inc. (November 2, 2026)
- Pelthos to merge with Castle Creek Biosciences (October 30, 2026)
Who to call at CorMedix, and when
When CorMedix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CorMedix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CorMedix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CorMedix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CorMedix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Heron Therapeutics?
Heron Therapeutics was acquired by CorMedix, based in Berkeley Heights. The deal was reported on November 10, 2026. CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is publicly traded (CRMD) and operates in Biotechnology.
When did CorMedix acquire Heron Therapeutics?
CorMedix's acquisition of Heron Therapeutics was reported on November 10, 2026. On November 9, 2026, CorMedix Inc. announced the execution of a definitive asset purchase agreement to acquire substantially all of the assets of Heron Therapeutics, Inc. This strategic move was disclosed during a conference call and webcast for investors. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Heron Therapeutics do?
At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter. It is privately held, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.